Souhaitez-vous accéder aux communiqués récents ?

60 Degrees Pharmaceuticals Announces First Quarter 2026 Results

Robust reductions in tau pathology were observed across all studied doses, with results generally consistent with those observed in the Phase 1b study1Pre-specified analyses of cognitive endpoints...

Reaffirms guidance to resubmit Anaphylm™ (dibutepinephrine) sublingual film NDA in Q3 2026Affirms existing clinical data is sufficient for submitting regulatory applications in Canada, European Union,...

CARDAMYST™ (etripamil) nasal spray launch for PSVT is gaining traction; breadth of unique prescribers supports potential future adoptionExpress Scripts national formulary coverage secured as company...

– Adds Highly Complementary and Differentiated Medicine with Significant Growth Potential to Collegium’s Existing ADHD Portfolio – – Extends Collegium’s Long-Term Revenue Outlook; AZSTARYS has...

AUSTIN, Texas, May 07, 2026 (GLOBE NEWSWIRE) -- Filana Therapeutics, Inc. (NASDAQ: FLNA, “Filana Therapeutics”, the “Company”), a biotechnology company currently focused on developing therapies for...

AUSTIN, Texas, May 05, 2026 (GLOBE NEWSWIRE) -- Filana Therapeutics, Inc. (NASDAQ: FLNA, “Filana Therapeutics”, the “Company”), a biotechnology company currently focused on developing therapies for...

Ashland reports second quarter fiscal 2026 results and updates full-year outlook

Austin, TX, USA, April 23, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Water and Wastewater Treatment Market Size, Trends and Insights By Treatment...

ARAKODA® now available via Runway Health, enabling U.S. travelers to access once-weekly malaria prevention through a convenient telehealth platform.